Home › Compare › BPIGF vs ABBV
BPIGF yields 2000000.00% · ABBV yields 3.06%● Live data
📍 BPIGF pulled ahead of the other in Year 1
Combined, BPIGF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BPIGF + ABBV for your $10,000?
BPI Energy Holdings, Inc., through its subsidiary, BPI Energy, Inc., engages in the acquisition, exploration, development, production, and sale of coalbed methane (CBM) properties in the United States. It owns approximately 500,000 acres of CBM rights in the Illinois Basin. The company also has interests in Southern Illinois Basin project covering approximately 10,000 acres in the southern part of the Illinois Basin; the Northern Illinois Basin project covering 353,531 acres in Montgomery, Shelby, Christian, Fayette, and Macoupin Counties in Illinois; and the Western Illinois Basin project covering 135,948 acres in Clinton, Washington, Marion, and Perry Counties in Illinois. As of July 31, 2007, it had 16,274 million cubic feet of total estimated proved developed and undeveloped reserves. The company was founded in 1980 and is headquartered in Solon, Ohio.
Full BPIGF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.